Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Renascience, The Current Fiscal Year's Net Income Turns to Loss
4889 Renascience Inc. 【J-GAAP】
Earnings ReportRenascience Inc. <4889> [TSE Growth] announced its financial results after the market closed on May 14th (15:30). The net income/loss (non-consolidated) for the fiscal year ending March 2025 turned into a profit of 113 million yen (compared to a loss of 258 million yen in the previous period). For the fiscal year ending March 2026, the net income/loss is expected to turn into a loss of 362 million yen.
In the most recent three-month period, from January to March (4Q), the net loss expanded to a loss of 41 million yen (compared to a loss of 36 million yen in the same period last year). The operating profit/loss margin drastically worsened from -41.9% in the same period last year to -58.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 100 | -333 | -333 | -335 | -26.4 | 0 | May 11, 2023 | J-GAAP |
| Mar, 2024 | 194 | -252 | -251 | -258 | -20.3 | 0 | May 9, 2024 | J-GAAP |
| Mar, 2025 | 132 | -178 | -178 | 113 | 8.9 | 0 | May 14, 2025 | J-GAAP |
| YoY | -32.0% | +29.4% | +29.1% | - | - |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 127 | -267 | -267 | 46 | 3.6 | 0 | Dec 6, 2024 | J-GAAP |
| Mar, 2025 Results | 132 | -178 | -178 | 113 | 8.9 | 0 | May 14, 2025 | J-GAAP |
| Revision Rate | +3.9% | +33.3% | +33.3% | +145.7% | +146.4% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 55 | -90 | -92 | -72 | -5.7 | 0 | Nov 14, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 0 | May 14, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 194 | -252 | -251 | -258 | -20.3 | 0 | May 9, 2024 | J-GAAP |
| Mar, 2025 | 132 | -178 | -178 | 113 | 8.9 | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 113 | -397 | -360 | -362 | -28.5 | 0 | May 14, 2025 | J-GAAP |
| YoY | -14.4% | -123.0% | -102.2% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 74 | -31 | -30 | -36 | -2.8 | -41.9 | May 9, 2024 | J-GAAP |
| Apr - Jun, 2024 | 40 | -36 | -36 | -16 | -1.3 | -90.0 | Aug 8, 2024 | J-GAAP |
| Jul - Sep, 2024 | 15 | -54 | -56 | -56 | -4.5 | -360.0 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 10 | -49 | -48 | 226 | 17.8 | -490.0 | Feb 13, 2025 | J-GAAP |
| Jan - Mar, 2025 | 67 | -39 | -38 | -41 | -3.2 | -58.2 | May 14, 2025 | J-GAAP |
| YoY | -9.5% | -25.8% | -26.7% | -13.9% | -14.1% |
Related Articles
TAYCA, 4% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Kubota Pharma, Jan-Mar (1Q) Net Income Loss Narrows
Immuno-Biological Lab, 15% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Resuming Dividends at 6 yen for the First Time in Thirteen Terms
AI Inc, 78% Decrease in Ordinary Profit for The Current Fiscal Year
Rakuten, Jan-Mar (1Q) Net Income Loss Widens
ORO, Jan-Mar (1Q) Net Income Decreases by 21%
NHK SPRING, 9% Decrease in Ordinary Profit for The Current Fiscal Year
TOKYO AUTOMATIC MACHINERY, 67% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend to Cut by 140 yen
JAPAN ELECTRONIC MATERIALS, 21% Decrease in Ordinary Profit for The Current Fiscal Year
TAZMO, Jan-Mar (1Q) Ordinary Profit Increases by 78%